Manchester medtech firm gains funding from Scottish Cervical Cancer charity

Willie Henderson, centre, with Maggie Cruickshank and Darren Neill

Zilico, the Manchester cervical cancer diagnostic specialist, continues to see the adoption of its ZedScan™ expand after the Michelle Henderson Cervical Cancer Trust funded the purchase of two ZedScan devices.

They will be used at Aberdeen Royal Infirmary’s colposcopy unit, to help prevent women developing cervical cancer.

ZedScan is a diagnostic device that uses electrical impendence spectroscopy technology to identify cell changes that cannot always be seen during standard colposcopy.

Changes in the cells of the cervix can lead to cervical cancer, but early detection of cell abnormalities and appropriate treatment can prevent cervical cancer from developing.

Michelle Henderson was just 26 when she was diagnosed with cervical cancer in 2010.

The diagnosis came as a shock to her whole family including her father, ex-Scotland football legend William ‘Willie’ Henderson.

Tragically, Michelle died of the disease just two years later, on her 28th birthday.

Since his daughter’s diagnosis Willie has been a key fundraiser for the Michelle Henderson Cervical Cancer Trust.

Michelle set up the organisation herself in the hope of raising awareness and funds towards hospital equipment, medicines and support for anyone diagnosed with the disease.

It is in her memory that the charity is supporting the purchase of the ZedScan devices for Aberdeen Royal Infirmary.

In February this year Zilico, based on Manchester Science Park, secured two major deals, totalling £14.5m, to support the company’s global expansion plans in China and the US for ZedScan.

Click here to sign up to receive our new South West business news...
Close